Shared Decision Making Between Cardiologists and Heart Valve Disease Patients
Millions of people worldwide are currently impacted by heart valve disease, and one in eight people aged 75 and older have the most common form, aortic stenosis (AS). Currently, treatment options for AS include transcatheter aortic valve replacement (TAVR), a minimally invasive procedure, or a surgical aortic valve replacement (SAVR), also known as open heart surgery.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Millions of people worldwide are currently impacted by heart valve disease, and one in eight people aged 75 and older have the most common form, aortic stenosis (AS).
- Key Point: Currently, treatment options for AS include transcatheter aortic valve replacement (TAVR), a minimally invasive procedure, or a surgical aortic valve replacement (SAVR), also kn…
- Key Point: Purvi Parwani, M.D., Director of the Women’s Cardiovascular Health Clinic at Loma Linda International Heart Institute discusses new findings from a CardioSurve survey, sponsored…
- Key Point: However, the survey also uncovered cardiologists feel that their symptomatic severe AS patients are not as informed as they should be about their treatment options.
- Key Point: Parwani will address why shared decision making is critical to individualized care and how to advance patient/physician dialogue.
Dr. Purvi Parwani, M.D., Director of the Women’s Cardiovascular Health Clinic at Loma Linda International Heart Institute discusses new findings from a CardioSurve survey, sponsored by Medtronic and conducted by the American College of Cardiology, that reveals more than half of cardiologists believe patient preparation may lead to better quality discussions around treatment options for heart valve disease. However, the survey also uncovered cardiologists feel that their symptomatic severe AS patients are not as informed as they should be about their treatment options. Dr. Parwani will address why shared decision making is critical to individualized care and how to advance patient/physician dialogue.
Purvi Parwani, M.D. currently serves as the director of the Women’s Cardiovascular Health Clinic at Loma Linda International Heart Institute. Dr. Parwani recently sat as a panelist the American College of Cardiology Virtual Symposium and discussed outcomes of the ACC CardioSurve panelist survey. Dr. Parwani graduated from the B.J. Medical College in Ahmedabad and is board certified by the American Board of Internal Medicine, Cardiovascular Disease and American Board of Internal Medicine, Internal Medicine.
Listen on Soundcloud.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



